IRCT20200515047456N1招募中3 期
Evaluation of Tissue Plasminogen Activator (tPA) in comparition of anticoagulation for treatment of critical COVID 19 patient
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 70 years（—）
- 性别
- All
入选标准
- •COVID patients with P/F ratio less than 100
- •D.dimer more than 3000 without response to other medications
排除标准
- •Active bleeding
- •Platelet less than 30000
- •Without any contraindication for thrombolytic therapy
研究者
相似试验
已完成
2 期
Effect of treatment with tissue plasminogen activator in improving clinical status of patients with acute ischemic strokeIRCT201709049014N182Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences40
尚未招募
不适用
Tissue Plasminogen Activator levels in Diabetic footCTRI/2020/07/026277AIIMS Bhubaneswar
已完成
3 期
tissue type plasminogen activator(t-PA) and Edaravon combination therapy studyAcute ischemic strokeJPRN-UMIN000006330eurology, Nippon Medical School200
已完成
不适用
Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern StudentsAcute StrokeNCT05462665Dokuz Eylul University75
招募中
不适用
t-PA trial for central retinal artery occlusioartery occlusionH341central retinal artery occlusionJPRN-jRCTs041190079Hayashi Atsushi20